GVK Biosciences row: India, EU to meet on Jan 18 in Brussels
India and EU are expected to meet on January 18 in Brussels.
Dec 30, 2015, 16:01 PM IST
FIPB clears 3 FDI proposals worth Rs 160 crore
The foreign investment promotion board today cleared three FDI proposals worth Rs 160 crore.
Nov 27, 2015, 19:22 PM IST
Germany suspends marketing of 54 drugs tested by India's GVK Bio
Germany has suspended marketing of 54 drugs tested by GVK Biosciences in compliance with the European Union's ban on around 700 generic drugs.
Aug 22, 2015, 11:09 AM IST
Drug ban not trade related, hopeful of solution: EU
The EU Friday defended the banning of around 700 generic drugs tested by India's GVK Biosciences, asserting it was based on "scientific and not trade considerations" and voiced hope that a solution will be found after India deferred FTA talks with the bloc over the issue.
Aug 07, 2015, 21:37 PM IST
India defers FTA talks with EU over ban of 700 pharma products
Expressing disappointment and concern over the EU banning sale of around 700 pharma products clinically tested by GVK Biosciences, India has deferred the talks with the European Union on the proposed free trade agreement.
Aug 05, 2015, 17:36 PM IST
EU suspends sale of 700 generic drugs made in India
European Union nations have until August 20 to suspend the sale of some 700 generic drugs made in India, the EU`s executive confirmed on Monday.
Jul 27, 2015, 23:55 PM IST
EU bans 700 generic drugs for manipulation of trials by GVK
The European Union has banned the marketing of around 700 generic medicines for alleged manipulation of clinical trials conducted by India's pharmaceutical research company GVK Biosciences.
Jul 25, 2015, 14:26 PM IST
Swedish pharma firm partners GVK Bio for drug research
Sweden-based pharmaceutical firm Medivir has entered into a partnership with GVK Biosciences for drug research.
Jun 16, 2015, 20:30 PM IST
Swissmedic examines drugs trialled by GVK Biosciences
The Swiss surveillance authority for medicines Friday checked for any corresponding preparations of the 700 generic medicines subjected to clinical trials by India's GVK Biosciences, whose marketing rights were suspended by the European Medicines Agency (EMA).
Feb 07, 2015, 00:59 AM IST
German regulator hails EMA's drugs suspension on GVK Bio data
German drug regulator has welcomed the European Medicine Agency's (EMA) decision to suspend the marketing authorisation of around 700 generic drugs subjected to clinical trials by India's GVK Biosciences.
Jan 24, 2015, 13:34 PM IST
GVK Bio offers to re-do studies after EU ruling
Pharmaceutical research company GVK Biosciences has offered to re-do studies at its own cost after the European Union suspended marketing approval of some generic drugs due to alleged manipulation of data related to clinical trials.
Dec 08, 2014, 19:49 PM IST
France, Germany suspend some drug approvals over Indian data
All of the drugs being suspended, several of which are manufactured by Mylan Inc and Abbott , have brand name equivalents that can be used instead, so patients will not have to interrupt their treatment.
Dec 06, 2014, 08:48 AM IST
GVK Bio under scanner of European Drug Regulator
The European Medicines Agency (EMA) has started a review in connection with findings of alleged non-compliance with good clinical practice (GCP) at a facility owned by GVK Biosciences, a city-based Contract Research Organisation.
Oct 01, 2014, 17:29 PM IST
